Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Geron Corp (NASDAQ: GERN) closed at $1.76 up 1.15% from its previous closing price of $1.74. In other words, the price has increased by $1.15 from its previous closing price. On the day, 12.91 million shares were traded.
Ratios:
For a deeper understanding of Geron Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.12 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on February 27, 2025, Downgraded its rating to Neutral and sets its target price to $2 from $3.50 previously.
On November 05, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $8.H.C. Wainwright initiated its Buy rating on November 05, 2024, with a $8 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 14.56 while its Price-to-Book (P/B) ratio in mrq is 3.81.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is -41.13%, while the 200-Day Moving Average is calculated to be -55.65%.
Shares Statistics:
A total of 606.39M shares are outstanding, with a floating share count of 597.86M. Insiders hold about 6.13% of the company’s shares, while institutions hold 71.82% stake in the company.
